Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33887731)

  • 1. Diagnostic Pitfalls Related to Morular Metaplasia in Endometrioid Carcinoma: An Underestimated Issue.
    Travaglino A; Raffone A; Gencarelli A; Saracinelli S; Zullo F; Insabato L
    Pathobiology; 2021; 88(3):261-266. PubMed ID: 33887731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2.
    Houghton O; Connolly LE; McCluggage WG
    Histopathology; 2008 Aug; 53(2):156-65. PubMed ID: 18752499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between morular metaplasia and squamous differentiation in endometrial carcinoma.
    Travaglino A; Raffone A; Gencarelli A; Raimondo D; Moretta P; Pignatiello S; Granata M; Seracchioli R; Zullo F; Insabato L
    Pathol Res Pract; 2021 Jan; 217():153307. PubMed ID: 33316539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
    Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
    Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia.
    Chiarelli S; Buriticá C; Litta P; Ciani S; Guarch R; Nogales FF
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4251-6. PubMed ID: 16857799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
    Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
    Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
    McCluggage WG; Young RH
    Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
    Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dedifferentiated carcinoma of the ovary. A case report.
    Němejcová K; Rosmusová J; Bártů M; Matěj R; Dundr P
    Cesk Patol; 2018; 54(1):33-36. PubMed ID: 29631410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SF-1 is a diagnostically useful immunohistochemical marker and comparable to other sex cord-stromal tumor markers for the differential diagnosis of ovarian sertoli cell tumor.
    Zhao C; Barner R; Vinh TN; McManus K; Dabbs D; Vang R
    Int J Gynecol Pathol; 2008 Oct; 27(4):507-14. PubMed ID: 18753972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature.
    Hatano Y; Tamada M; Asano N; Hayasaki Y; Tomita H; Morishige KI; Hara A
    Diagn Pathol; 2019 Jan; 14(1):4. PubMed ID: 30636633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers.
    Ramalingam P; Masand RP; Euscher ED; Malpica A
    Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
    Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
    APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does endometrial morular metaplasia represent odontogenic differentiation?
    Travaglino A; Raffone A; Russo D; Guadagno E; Pignatiello S; Moretta P; Zullo F; Del Basso De Caro M; Insabato L; Mascolo M
    Virchows Arch; 2021 Sep; 479(3):607-616. PubMed ID: 33666744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian Endometrioid Carcinoma Misdiagnosed as Mucinous Carcinoma: An Underrecognized Problem.
    Woodbeck R; Kelemen LE; Köbel M
    Int J Gynecol Pathol; 2019 Nov; 38(6):568-575. PubMed ID: 30480647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic intestinal carcinomas simulating primary ovarian clear cell carcinoma and secretory endometrioid carcinoma: a clinicopathologic and immunohistochemical study of five cases.
    Young RH; Hart WR
    Am J Surg Pathol; 1998 Jul; 22(7):805-15. PubMed ID: 9669343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor: report of a series of cases.
    Mansor S; McCluggage WG
    Int J Gynecol Pathol; 2014 Sep; 33(5):470-6. PubMed ID: 25083962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
    Murali R; Davidson B; Fadare O; Carlson JA; Crum CP; Gilks CB; Irving JA; Malpica A; Matias-Guiu X; McCluggage WG; Mittal K; Oliva E; Parkash V; Rutgers JKL; Staats PN; Stewart CJR; Tornos C; Soslow RA
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.